Investor Presentation
Q2 2021 vs. Q2 2020 Reconciliation
Operating Income, Net Income Per Share
REPLIGEN CORPORATION
RECONCILIATION OF GAAP INCOME FROM OPERATIONS TO
NON-GAAP (ADJUSTED) INCOME FROM OPERATIONS
(Unaudited, amounts in thousands)
GAAP INCOME FROM OPERATIONS
ADJUSTMENTS TO INCOME FROM OPERATIONS:
Inventory step-up charges
Acquisition and integration costs
Intangible amortization
ADJUSTED INCOME FROM OPERATIONS
$
Totals may not add due to rounding
Three Months Ended
June 30,
2021
48,240 $
3,218
5,161
2020
19,537
2,134
3,874
Six Months Ended
June 30,
2021
$ 84,623 $
1,598
5,769
10,323
2020
31,443
4,687
7,752
$ 56,619 $ 25,545 $ 102,313 $ 43,882
REPLIGEN CORPORATION
RECONCILIATION OF GAAP NET INCOME PER SHARE TO
NON-GAAP (ADJUSTED) NET INCOME PER SHARE
(Unaudited)
GAAP NET INCOME PER SHARE - DILUTED
$
ADJUSTED NET INCOME PER SHARE - DILUTE $
Totals may not add due to rounding.
Three Months Ended
June 30,
2021
ADJUSTMENTS TO NET INCOME PER SHARE - DILUTED:
Inventory step-up charges
Acquisition and integration costs
Intangible amortization
Loss on conversion of debt
Non-cash interest expense
Tax effect of non-GAAP charges
0.64 $
0.06
0.09
0.00
0.05
(0.05)
0.79
R REPLIGEN
INSPIRING ADVANCES IN BIOPROCESSING
$
2020
0.30 $
0.04
0.07
0.05
(0.04)
0.42
$
Six Months Ended
June 30,
2021
1.16
0.03
0.10
0.18
0.00
0.10
(0.10)
1.47
$
$
2020
0.48
0.09
0.15
0.10
(0.08)
0.74
35View entire presentation